WORLDWIDE EVIDENCE
LIVE

Serial Number

87689214

Owner

Worldwide Clinical Trials, Inc.

Attorney

Lindsay Lehrer

First Use Date

Jun 30, 2018

Filing Date

Nov 17, 2017

Add to watchlist:

No watchlists yet
View on USPTO

WORLDWIDE EVIDENCE Trademark

Serial Number: 87689214 • Registration: 5777758

WORLDWIDE EVIDENCE is a trademark filed by Worldwide Clinical Trials, Inc. on November 17, 2017. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Worldwide Clinical Trials, Inc. (11 trademarks)

8500 Wilshire Boulevard
Beverly Hills, CA 90211

Entity Type: 03

Trademark Details

Filing Date

November 17, 2017

Registration Date

June 11, 2019

First Use Anywhere

June 30, 2018

First Use in Commerce

June 30, 2018

Goods & Services

Pharmaceutical research services; Pharmaceutical research and development; Technical writing of clinical report forms for others which are required by clinical trial study protocols; Technical writing of clinical trial reports for others; Database development services to process data collected from clinical trials

Training clinical trial site personnel concerning protocol requirements and the use of tests and rating systems for such protocol; training clinical trial site personnel in the use of medical and research equipment and procedures required by protocols

Business consulting and management in the field of clinical trials; Pharmaceutical cost management services and drug utilization review services; Business management assistance and consultation for clinical trials of observational research designs, namely, management and compilation of information in the field of clinical trials for business purposes, namely, surveys, retrospective chart review, prospective longitudinal cohort studies, post approval safety studies (pass), registries, and interventional studies for approved and investigational drugs; Business management services, namely, arranging for sites to perform clinical trials, arranging for the import, packaging, shipping labeling, and distribution of drugs and other investigational supplies to and from the clinical trial sites as appropriate to the study design, arranging for the central collection of laboratory specimens from clinical trial sites, extracting data from clinical trial records including electronic healthcare records, making any and all filings required by the food and drug administration as well as the EMA for observational research, and as appropriate investigational new drugs, preparing statistical reports resulting from clinical trials an studies, all for business purposes

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Mar 24, 2026 NAS8
REGISTERED - SEC. 8 (6-YR) ACCEPTED
Mar 24, 2026 8.OK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 23, 2026 APRE
TEAS SECTION 8 RECEIVED
Nov 4, 2025 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 11, 2024 REM1
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Dec 20, 2023 ASCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 1, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 1, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 1, 2022 REAP
REGISTERED-SUPPLEMENTAL REGISTER
Jun 11, 2019 R.SR
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 3, 2019 PREV
ASSIGNED TO LIE
Apr 29, 2019 ALIE
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Apr 19, 2019 AAUA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Apr 18, 2019 CNTA
USE AMENDMENT ACCEPTED
Apr 18, 2019 IUAA
AMENDMENT TO USE PROCESSING COMPLETE
Apr 16, 2019 AUPC
USE AMENDMENT FILED
Apr 16, 2019 IUAF
TEAS AMENDMENT OF USE RECEIVED
Apr 15, 2019 EAAU
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 12, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 11, 2019 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 11, 2019 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 15, 2018 GNFN
FINAL REFUSAL E-MAILED
Oct 15, 2018 GNFR
FINAL REFUSAL WRITTEN
Oct 15, 2018 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 13, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 12, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 12, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 12, 2018 GNRN
NON-FINAL ACTION E-MAILED
Mar 12, 2018 GNRT
NON-FINAL ACTION WRITTEN
Mar 12, 2018 CNRT
ASSIGNED TO EXAMINER
Mar 2, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 30, 2017 NWOS
NEW APPLICATION ENTERED
Nov 21, 2017 NWAP